Adrenomed’s goal is to fill the gap in patient treatment further downstream of inflammation with Adrecizumab, the first sepsis therapy candidate to target an important causal pathophysiology of ...

Advances in the understanding of the pathophysiology of sepsis have occurred in the last decade. Previously, sepsis was viewed primarily as an inflammatory disorder. More recent studies indicate ...

It's a copycat killer—often mimicking less severe conditions and delaying much-needed, timely treatments. But sepsis—an ...

Despite similar clinical presentations, the molecular and cellular processes that elicit the sepsis response differ depending on whether the organism is gram-negative, gram-positive, fungal ...

Like a poison pen, dying cells prick their neighbors with a lethal message. This may worsen sepsis, Vijay Rathinam and colleagues in the UConn School of Medicine report in the Jan. 23 issue of Cell.

One night he was looking after a baby boy who had sepsis, which is where the immune ... It feels like we're discovering ...